Engineered Receptors for Soluble Cell-to-Cell Communication

Dan I. Piraner,Mohamad H. Abedi,Maria J. Duran Gonzalez,Adam Chazin-Gray,Iowis Zhu,Pavithran T. Ravindran,Thomas Schlichthaerle,Buwei Huang,David Lee,David Baker,Kole T. Roybal

DOI: https://doi.org/10.1101/2024.09.17.613377

2024-09-18

Abstract:Despite recent advances in mammalian synthetic biology, there remains a lack of modular synthetic receptors that can robustly respond to soluble ligands and in turn activate cellular functions. Such receptors would have extensive clinical potential to regulate the activity of engineered therapeutic cells, but to date only receptors against cell surface targets have approached clinical translation. To address this gap, we developed a receptor architecture based on synNotch, called SyNthetic Intramembrane Proteolysis Receptor (SNIPR), that has the added ability to be activated by soluble ligands, both natural and synthetic, with remarkably low baseline activity and high fold activation. SNIPRs are able to access an endocytic, pH-dependent cleavage mechanism to achieve soluble ligand sensing, in addition to employing a canonical-like pathway for detecting surface-bound ligands. We demonstrate the therapeutic capabilities of the receptor platform by localizing the activity of CAR T-cells to solid tumors where soluble disease-associated factors are expressed, bypassing the major hurdle of on-target off-tumor toxicity in bystander organs. We further applied the SNIPR platform to engineer fully synthetic signaling networks between cells orthogonal to natural signaling pathways, expanding the scope of synthetic biology. Our design framework enables cellular communication and environmental interactions, extending the capabilities of synthetic cellular networking in clinical and research contexts.

Bioengineering

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop synthetic receptors that can respond to soluble ligands and activate cellular functions, in order to overcome the limited progress in the development of biosensors that are sensitive to soluble factors and robust in existing synthetic biology. Specifically, the paper introduces a novel receptor architecture based on synNotch - SyNthetic Intramembrane Proteolysis Receptor (SNIPR). This receptor can be activated not only by natural and synthetic soluble ligands, but also has extremely low basal activity and a high - fold activation ability. SNIPR senses soluble ligands through a pH - dependent cleavage mechanism in endocytosis and can detect surface - bound ligands through a similar classical pathway. The paper further demonstrates the potential application of the SNIPR platform in cancer treatment. For example, it can localize the activity of CAR T cells to solid tumors expressing disease - related factors, thereby bypassing the major obstacle of off - target non - tumor toxicity in bystander organs. In addition, a completely synthetic intercellular signaling network has been constructed using the SNIPR platform. These networks operate independently of natural signaling pathways, expanding the scope of synthetic biology. These design frameworks enable intercellular communication and environmental interaction, enhancing the capabilities of synthetic cell networks in clinical and research settings.

Engineered Receptors for Soluble Cell-to-Cell Communication

Engineered receptors for soluble cellular communication and disease sensing

Modular design of synthetic receptors for programmed gene regulation in cell therapies

Programmable synthetic receptors: the next-generation of cell and gene therapies.

Conversion of natural cytokine receptors into orthogonal synthetic biosensors

Elucidation and refinement of synthetic receptor mechanisms

Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions

Chemically Synthetic Membrane Receptors Establish Cells with Artificial Sense-and-Respond Signaling Pathways

Synthetic Receptors for Sensing Soluble Molecules with Mammalian Cells

Engineering synthetic agonists for targeted activation of Notch signaling

Engineering an anti-CD206-synNotch receptor: insights into the development of novel synthetic receptors

The evolution of synthetic receptor systems

SyNPL: Synthetic Notch pluripotent cell lines to monitor and manipulate cell interactions in vitro and in vivo

Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices

Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor

Artificial Internalizing Receptor Affords Fast, Potent, Specific Drug Delivery to the Chemically Engineered Cells

A synthetic metabolite-based mammalian inter-cell signaling system

Post-Transcriptional Modular Synthetic Receptors

Synthetic G protein-coupled receptors for programmable sensing and control of cell behavior

Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming

Chemically inducible split protein regulators for mammalian cells